(Q36284603)

English

Malaria during Pregnancy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Malaria during Pregnancy (English)

1 reference

Europe PubMed Central

13 August 2017

maternal health

0 references

0 references

pregnancy-associated malaria

1 reference

based on heuristic

inferred from title

Patrick Emmet Duffy

2

object named as

Patrick E Duffy

1 reference

Europe PubMed Central

13 August 2017

author name string

Michal Fried

1

1 reference

Europe PubMed Central

13 August 2017

publication date

17 February 2017

1 reference

Europe PubMed Central

13 August 2017

Cold Spring Harbor Perspectives in Medicine

1 reference

Europe PubMed Central

13 August 2017

7

1 reference

Europe PubMed Central

13 August 2017

6

1 reference

Europe PubMed Central

13 August 2017

Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Clinical malaria in African pregnant women

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Parity-dependent recognition of DBL1X-3X suggests an important role of the VAR2CSA high-affinity CSA-binding region in the development of the humoral response against placental malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

CXC ligand 9 response to malaria during pregnancy is associated with low-birth-weight deliveries

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Pregnancy malaria: cryptic disease, apparent solution

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Malaria cellular immune responses in neonates from Cameroon.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Maternal antibodies block malaria.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Diagnosing malaria in pregnancy: an update

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Drugs for preventing malaria in pregnant women

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Parasite burden and severity of malaria in Tanzanian children

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Malaria chemoprophylaxis, birth weight and child survival

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Placental pathology in malaria: a histological, immunohistochemical, and quantitative study

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Fetal responses during placental malaria modify the risk of low birth weight

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Cytokine profiles at birth predict malaria severity during infancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Evaluation of the OptiMAL rapid antigen test and species-specific PCR to detect placental Plasmodium falciparum infection at delivery

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

How hidden can malaria be in pregnant women? Diagnosis by microscopy, placental histology, polymerase chain reaction and detection of histidine-rich protein 2 in plasma

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Haemozoin as a marker of placental parasitization.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Diagnosis of placental malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southweste

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Malaria during pregnancy in an area of unstable endemicity

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Massive chronic intervillositis of the placenta associated with malaria infection.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Evidence for the involvement of VAR2CSA in pregnancy-associated malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Placental malaria increases malaria risk in the first 30 months of life

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Changes in the Levels of Chemokines and Cytokines in the Placentas of Women withPlasmodium falciparumMalaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Performance of the OptiMAL dipstick in the diagnosis of malaria infection in pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

High level of var2csa transcription by Plasmodium falciparum isolated from the placenta

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Accuracy of an HRP-2/panLDH rapid diagnostic test to detect peripheral and placental Plasmodium falciparum infection in Papua New Guinean women with anaemia or suspected malaria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Comparison of the OptiMAL rapid test and microscopy for detection of malaria in pregnant women in Nigeria

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Non-falciparum malaria infections in pregnant women in West Africa

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Comparison of a rapid field immunochromatographic test to expert microscopy for the detection of Plasmodium falciparum asexual parasitemia in Thailand.

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

21 January 2018

Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmodium falciparum: adhesion of placental isolates modulated by the sulfation characteristics of the glycosaminoglycan receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a malaria rapid diagnostic test for assessing the burden of malaria during pregnancy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of malaria in pregnancy in Africa

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology, malaria and pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28213434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1101/CSHPERSPECT.A025551

1 reference

Europe PubMed Central

13 August 2017

0 references

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36284603&oldid=1979021094"